Premarket movers: AstraZeneca investment lifts SMMT; IOVA guidance raised
In premarket trading, SMMT rose on a reported $2 billion AstraZeneca investment. IOVA gained after raising full-year 2026 revenue guidance to $410–$420 million. Other gainers included FCEL (+9.5% on initiating OUTPERFORM), NVTS (U.S. government selection to develop next-generation 10 kV SiC power semiconductors), UEC (+6.5% on earnings), KMX (+6% on earnings), PLUG (+5.5% on strategic partnership), BFLY (+4% initiating OUTPERFORM), and BE (+3% with a Jefferies PT raise and RBC positive comments.
Top Big Cap Positive News Movers Premarket: SMMT: +20% $2 Billion AstraZeneca Investment IOVA: +14% Raises Full Year 2026 Revenue Guidance to $410 to $420 Million FCEL: +9.5% Initiated OUTPERFORM @ Opp. NVTS: +9% U.S. Government Selects Navitas to Develop Next-Generation 10 kV SiC Power Semiconductors UEC: +6.5% Earnings KMX: +6% Earnings PLUG: +5.5% Plug and Arcadia eFuels Sign Strategic Partnership BFLY: +4% Initiated OUTPERFORM @ Evercore BE: +3% PT Raised at Jefferies -- RBC positive comments